Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.440
-0.040 (-1.61%)
At close: Sep 18, 2024, 4:00 PM
2.445
+0.005 (0.20%)
After-hours: Sep 18, 2024, 7:20 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $146.59 million as of September 18, 2024. Its market cap has decreased by -58.54% in one year.
Market Cap
146.59M
Enterprise Value
-105.06M
1-Year Change
-58.54%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $146.59M, a decrease of -76.30%. That is a compound annual growth rate of -36.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 149.00M | -33.00% |
| Dec 29, 2023 | 222.40M | 0.63% |
| Dec 30, 2022 | 221.00M | -19.23% |
| Dec 31, 2021 | 273.60M | -55.76% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ventyx Biosciences | 161.83M |
| Lifecore Biomedical | 160.05M |
| Tenaya Therapeutics | 157.78M |
| Electromed | 157.49M |
| Context Therapeutics | 156.75M |
| Achieve Life Sciences | 155.57M |
| Adagene | 154.51M |
| Actuate Therapeutics | 153.08M |